Aegerion Pharma (AEGR) Misses Q2 EPS by 34c

August 9, 2016 4:12 PM EDT
Get Alerts AEGR Hot Sheet
Trade AEGR Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Aegerion Pharma (NASDAQ: AEGR) reported Q2 EPS of ($0.72), $0.34 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $44.5 million versus the consensus estimate of $35.5 million.

For earnings history and earnings-related data on Aegerion Pharma (AEGR) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment